Targeted Immunotherapy: An Update with Special Emphasis on Ovarian Cancer

Authors

  • Anthony Maraveyas Imperial Cancer Research Fund, Oncology Group, Department of Clinical Oncology, Royal Postgraduate Medical School, Hammersmith Hospital, DuCane Rd., London, W12 0HS, England
  • Agamemnon Anthony Epenetos Imperial Cancer Research Fund, Oncology Group, Department of Clinical Oncology, Royal Postgraduate Medical School, Hammersmith Hospital, DuCane Rd., London, W12 0HS, England

DOI:

https://doi.org/10.3109/02841869309096130

Abstract

An overview of antibody-guided immunotherapy for neoplasia is presented. The diversity of the antibody molecule is highlighted, through the many sophisticated strategies proposed and employed, to overcome a number of problems impeding successful targeting. An update of radioimmunotherapy of ovarian cancer is presented and the exciting concepts that are introduced to the field of targeted cancer therapy by molecular biology and genetic engineering are addressed.

Downloads

Download data is not yet available.

Downloads

Published

1993-01-01

How to Cite

Maraveyas, A. ., & Anthony Epenetos, A. (1993). Targeted Immunotherapy: An Update with Special Emphasis on Ovarian Cancer. Acta Oncologica, 32(7-8), 741–746. https://doi.org/10.3109/02841869309096130

Issue

Vol. 32 No. 7-8 (1993): Acta Oncologica

Section

Articles